Skip to content
10-Q

Quarterly Report

SOLENO THERAPEUTICS INC

0000950170-25-104220

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 53.15M sh
Shares Diluted Q2 2025 · Jun 30, 2025 50.48M sh
Shares Diluted Q2 2025 · Jun 30, 2025 48.34M sh
Shares Diluted Q2 2025 · Jun 30, 2024 38.63M sh
Shares Diluted Q2 2025 · Jun 30, 2024 37.42M sh
Capex Q2 2025 · Jun 30, 2025 $14K
Capex Q2 2025 · Jun 30, 2024 $19K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$45.36M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.18M
Long Term Debt Q2 2025 · Jun 30, 2025 $49.85M
Long Term Debt Q2 2025 · Dec 31, 2024 $49.83M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $76.5M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $87.93M
Stockholders Equity Q2 2025 · Jun 30, 2025 $240.14M
Stockholders Equity Q2 2025 · Mar 31, 2025 $232.26M
Stockholders Equity Q2 2025 · Dec 31, 2024 $245.11M
Stockholders Equity Q2 2025 · Jun 30, 2024 $280.76M
Stockholders Equity Q2 2025 · Mar 31, 2024 $143.39M
Stockholders Equity Q2 2025 · Dec 31, 2023 $157.51M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.94M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.75M
Total Liabilities Q2 2025 · Jun 30, 2025 $92.17M
Total Liabilities Q2 2025 · Dec 31, 2024 $85.86M
Current Assets Q2 2025 · Jun 30, 2025 $316.79M
Current Assets Q2 2025 · Dec 31, 2024 $293.89M
Total Assets Q2 2025 · Jun 30, 2025 $332.31M
Total Assets Q2 2025 · Dec 31, 2024 $330.97M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.00
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.16
Eps Basic Q2 2025 · Jun 30, 2025 −$0.09
Eps Basic Q2 2025 · Jun 30, 2025 −$1.00
Eps Basic Q2 2025 · Jun 30, 2024 −$0.57
Eps Basic Q2 2025 · Jun 30, 2024 −$1.16
Sga Expense Q2 2025 · Jun 30, 2025 $28.24M
Sga Expense Q2 2025 · Jun 30, 2025 $57.5M
Sga Expense Q2 2025 · Jun 30, 2024 $10.89M
Sga Expense Q2 2025 · Jun 30, 2024 $19.36M
Rd Expense Q2 2025 · Jun 30, 2025 $9.15M
Rd Expense Q2 2025 · Jun 30, 2025 $22.66M
Rd Expense Q2 2025 · Jun 30, 2024 $12.34M
Rd Expense Q2 2025 · Jun 30, 2024 $26.94M
Net Income Q2 2025 · Jun 30, 2025 −$4.71M
Net Income Q2 2025 · Jun 30, 2025 −$48.48M
Net Income Q2 2025 · Mar 31, 2025 −$43.77M
Net Income Q2 2025 · Jun 30, 2024 −$21.85M
Net Income Q2 2025 · Jun 30, 2024 −$43.25M
Net Income Q2 2025 · Mar 31, 2024 −$21.4M
Operating Income Q2 2025 · Jun 30, 2025 −$6.53M
Operating Income Q2 2025 · Jun 30, 2025 −$52.27M
Operating Income Q2 2025 · Jun 30, 2024 −$24.87M
Operating Income Q2 2025 · Jun 30, 2024 −$48.34M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $696K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $696K